A Phase I/II Trial of ZIO-101 in Advanced Multiple Myeloma
A Phase I/II Trial of ZIO-101 in Advanced Multiple Myeloma
The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma
Subjects with multiple myeloma who have received at least two prior therapies and currently require therapy.